2021 Influenza Vaccine & COVID-19 Vaccine Update
|When||Wednesday February 24, 2021 at 7:30pm|
Seqirus invites you to this webinar featuring the launch of FLUCELVAX® QUAD, the first cell-based influenza vaccine available in Australia.
This live webcast will also provide an update on COVID-19 vaccines, and will feature three key speakers:
Dr Russell Basser, Senior Vice President, Research & Development, will discuss
Seqirus’ commitment to innovation and the development of influenza vaccine cell technology.
Prof. Robert Booy, Infectious diseases and immunisation expert, outlines the clinical profile of FLUCELVAX® QUAD.
Dr Jonathan Anderson, Head of Seqirus Medical Affairs, Asia Pacific, discusses
the 2020 & 2021 influenza seasons, and provides an update on COVID-19 vaccines.